{"slideshow_credits": null, "snippet": "If you look at the fine print, a judge\u2019s ruling this week may open up a new line of attack against the hedge fund manager William Ackman, Peter Henning and Steven Davidoff Solomon write.", "abstract": "If you look at the fine print, a judge\u2019s ruling this week may open up a new line of attack against the hedge fund manager William Ackman, Peter Henning and Steven Davidoff Solomon write.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"lastname": "HENNING", "rank": 1, "firstname": "Peter", "role": "reported", "organization": "", "middlename": "J."}, {"lastname": "SOLOMON", "rank": 2, "firstname": "Steven", "role": "reported", "organization": "", "middlename": "Davidoff"}], "original": "By PETER J. HENNING and STEVEN DAVIDOFF SOLOMON"}, "web_url": "http://dealbook.nytimes.com/2014/11/06/in-war-over-botox-maker-allergan-technicalities-can-be-tricky/", "lead_paragraph": null, "headline": {"main": "In War Over Botox Maker Allergan, Technicalities Can Be Tricky", "kicker": "DealBook"}, "_id": "545bce0d38f0d85e5ee91355", "word_count": "1393", "multimedia": [{"height": 126, "url": "images/2014/11/07/business/dbpix-white-collar-prof1/dbpix-white-collar-prof1-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/11/07/business/dbpix-white-collar-prof1/dbpix-white-collar-prof1-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/11/07/business/dbpix-white-collar-prof1/dbpix-white-collar-prof1-articleLarge.jpg", "legacy": {"xlarge": "images/2014/11/07/business/dbpix-white-collar-prof1/dbpix-white-collar-prof1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/11/07/business/dbpix-white-collar-prof1/dbpix-white-collar-prof1-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/11/07/business/dbpix-white-collar-prof1/dbpix-white-collar-prof1-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-11-06T14:36:10Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Ackman, William A", "name": "persons", "rank": "1"}, {"value": "Carter, David O", "name": "persons", "rank": "2"}, {"value": "Allergan Inc", "name": "organizations", "rank": "1"}, {"value": "Pershing Square Capital Management", "name": "organizations", "rank": "2"}, {"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "3"}, {"value": "Insider Trading", "name": "subject", "rank": "1"}, {"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "2"}, {"value": "Suits and Litigation (Civil)", "name": "subject", "rank": "3"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}